• AbbVie partners with Caraway on Parkinson’s therapeutics pharmaceutical-technology
    June 11, 2021
    AbbVie has signed an exclusive, collaboration and option agreement for the development and commercialisation of Caraway Therapeutics’ small molecule candidates to treat Parkinson’s disease and other related conditions.
PharmaSources Customer Service